Andrea Carfi, Ph.D.
VP & Head of Research, Infectious Disease, Moderna Inc.
Philip R. Dormitzer, M.D., Ph.D.
Vice President and Chief Scientific Officer, Viral Vaccines, Pfizer
Kathleen Maletic Neuzil, MD, MPH, FIDSA
Director, Center for Vaccine Development and Global Health, UMSOM
Julie A. Ake, M.D.
Director, US Military HIV Research Program
Jerald C. Sadoff, M.D.
Senior Advisor Vaccine Development, Janssen Vaccines & Prevention B.V.
Derek T. O' Hagan, BPharm, MRPharmS, Ph.D.
Senior Advisor Vaccines R&D, GSK
Pei-Yong Shi, Ph.D.
John Sealy Distinguished Chair in Innovations in Molecular Biology UTMB at Galveston
Jacqueline M. Miller, M.D., FAAP
Sr. VP & Therapeutic Area Head, Infectious Disease, Moderna Inc
Adrian McDermott, Ph.D.
Chief, Vaccine Immunology Program, NIAID, NIH
Dan H. Barouch, M.D., Ph.D.
Director, Center for Virology and Vaccine Research, BIDMC
Kate Broderick, Ph.D.
Senior Vice President, R&D, INOVIO
Doran L. Fink, M.D., Ph.D.
Deputy Director - Clinical, Division of Vaccines and Related Products Applications FDA/CBER
Trudy Morrison, Ph.D.
Professor, University of Massachusetts Medical School
Alexandre Le Vert, M.S.
Executive Chairman and Cofounder OSIVAX
Alexander Bukreyev, Ph.D.
Professor, University of Texas Medical Branch at Galveston
David B. Weiner, Ph.D.
Director, The Wistar Institute
Marcus A. Horwitz, M.D.
Professor, UCLA School of Medicine
Yingxia Wen, Ph.D.
Sr. Director, Head of Discovery Research at Seqirus
Michael G. Hanna Jr., Ph.D.
Director, Chairman Emeritus, Vaccinogen Inc.
George N. Pavlakis, M.D., Ph.D.
Chief, Human Retrovirus Section, Vaccine Branch, CCR, NCI
Vincent K. Tuohy, Ph.D.
Professor, Lerner College of Medicine, Cleveland Clinic
Sylvie Alonso, Ph.D.
Deputy Director, Life Sciences Institute, NUS, Singapore
Nathaniel R. Landau, Ph.D.
Professor, Department of Microbiology, NYU Grossman School of Medicine
Geoffrey Lynn, Ph.D.
CEO and Co-founder, Avidea Technologies, Baltimore
Matthew Frieman, Ph.D.
Assoc. Prof., Department of Microbiology and Immunology, UMSOM
David Martinez, Ph.D.
Hanna H. Gray Fellow of Howard Hughes Medical Institute, UNC-Chapel Hill
M. Javad Aman, Ph.D.
President and CSO, Integrated BioTherapeutics
Catarina Hioe, Ph.D.
Professor, Icahn School of Medicine at Mount Sinai
Jennifer Rainho-Tomko, Ph.D.
Scientist II, Sanofi Pasteur
Yongjun Sui, Ph.D.
Associate Scientist, Vaccine Branch, CCR, NCI
Oreola Donini, Ph.D.
Chief Scientific Officer, Soligenix, Inc.
Kaitlyn M. Morabito, Ph.D., M.S.
Program Officer, Flaviviruses, Virology Branch, Division of Microbiology and Infectious Diseases, NIAID, NIH
Marie-Claire Gauduin, Ph.D.
Associate Professor, Disease Intervention and Prevention, Texas Biomedical Research Institute
Janet Lathey, Ph.D.
Program Officer, Office of Biodefense, Research Resources, and Translational Research, DMID/NIAID/NIH
Tracy Ruckwardt Ph.D.
Staff Scientist and Unit Head, Vaccine Immunobiology Unit, NIAID, NIH
Masaru Kanekiyo D.V.M., Ph.D.
Earl Stadtman Investigator, Chief, Molecular Immunoengineering Section, VRC, NIAID/NIH
Eric Andrew Appel Ph.D.
Assistant Professor, Department of Materials Science & Engineering, Stanford University
Michael A Schotsaert Ph.D.
Assistant Professor, Microbiology, Icahn School of Medicine at Mount Sinai
Scott Burkholz M.S.
Bioinformatics Data Scientist, Flow Pharma
Heather Friberg Ph.D.
Chief, Department of Virus-Host Interactions, Viral Diseases Branch, WRAIR
Purnima Dubey Ph.D.
Associate Professor Department of Microbiology, The Ohio State University
Rama Rao Amara Ph.D.
Associate Director, Vaccine Development, Emory Vaccine Center
Benjamin Doranz Ph.D.
President, Integral Molecular
Andrew Lees Ph.D.
CEO/CSO, Fina Biosolutions
M. Sohaib Khan
University of Pittsburgh Graduate School of Public Health